Edgewell Personal Care Company EPC
27.82
0.49
1.79%
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 0.0×
Follow EPC
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 39.15 |
+8 more quarters Free account |
P/S ratio |
0.55 | 0.44 | 0.36 | 0.43 | |
P/FCF ratio |
23.63 | 20.42 | 21.89 | 23.36 | |
P/Operating CF |
10.43 | 18.27 | (6.31) | 13.05 | |
P/B ratio |
0.85 | 0.69 | 0.53 | 0.62 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.94 | 0.88 | 0.95 | 0.97 | |
EV/EBITDA |
21.20 | 15.96 | 13.56 | 11.64 | |
EV/Operating CF |
17.49 | 16.80 | 19.67 | 18.23 | |
EV/FCF |
40.46 | 40.56 | 58.57 | 52.14 | |
Quick Ratio |
0.86 | 0.79 | 0.76 | 0.64 | |
Current Ratio |
1.84 | 1.81 | 2.12 | 1.76 | |
Net Debt/EBITDA |
19.45 | 25.19 | 540.63 | 70.16 | |
Debt/Assets |
35.22% | 35.22% | 40.36% | 36.83% | |
Debt/Equity |
0.85 | 0.86 | 1.02 | 0.89 | |
Asset Turnover |
0.61 | 0.61 | 0.60 | 0.59 | |
Operating CF/Net income |
8.66 | (5.12) | 1.92 | (2.42) | |
Capex/Depreciation |
(0.84) | (0.73) | (0.54) | (1.19) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.33% | 2.87% | 3.26% | 2.37% | |
Selling, General and Administrative Expense of Revenue |
33.59% | 32.65% | 35.00% | 25.51% | |
Intangible Assets out of Total Assets |
0.55 | 0.55 | 0.52 | 0.52 | |
Share Based Compensation of Revenue |
1.00% | 1.08% | 0.80% | 0.78% | |
Graham Net Nets |
(0.78) | (0.98) | (1.54) | (1.25) | |
Graham Number |
0.00 | 0.00 | 0.00 | 19.56 | |
Earnings Yield |
(7.45%) | (7.87%) | (4.99%) | 2.55% | |
Free Cash Flow Yield |
4.23% | 4.90% | 4.57% | 4.28% | |
Revenue per Share |
12.37 | 11.17 | 9.07 | 15.40 | |
Operating CF per Share |
2.57 | 1.17 | (2.70) | 1.56 | |
Capex per Share |
(0.34) | (0.30) | (0.25) | (0.58) | |
Free Cash Flow per Share |
2.24 | 0.87 | (2.95) | 0.98 | |
Cash per Share |
8.61 | 6.45 | 4.79 | 4.75 | |
Shareholders Equity per Share |
31.67 | 31.14 | 31.89 | 32.70 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
31.67 | 31.14 | 31.89 | 32.70 | |
Free Cash Flow |
103.10 | 40.30 | (137.50) | 46.50 | |
Working Capital |
508.40 | 495.70 | 559.60 | 430.00 | |
Capital Expenditures |
(15.60) | (14.00) | (11.60) | (27.60) | |
Net Current Asset Value |
(963.50) | (975.60) | (1,224.60) | (1,207.70) | |
EV/EBIT |
119.11 | 52.14 | 31.08 | 22.35 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.04 | |
Net Profit Margin |
2.40% | (2.04%) | (15.54%) | (4.18%) | |
Price to Operating Income |
69.56 | 26.25 | 11.62 | 10.01 | |
| Other line items | |||||
Average Receivables |
136.30 | 181.80 | 137.25 | 123.60 | |
Average Payables |
227.60 | 223.35 | 208.45 | 219.50 | |
Average Inventory |
460.70 | 481.15 | 481.40 | 455.55 | |
Average Assets |
3,664.35 | 3,653.00 | 3,735.15 | 3,743.60 | |
Average Common Equity |
1,513.95 | 1,481.00 | 1,493.60 | 1,568.60 |
Columns are period end dates